Hikma Pharmaceuticals PLC ADR (HKMPY PINK) stock market data APIs
$45.1095
0.33(0.7%)
as of September 17, 2025
Try our APIs with
free plan!
Hikma Pharmaceuticals PLC ADR Financial Data Overview
Price chart is built with
Anychart
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Generics segment offers oral, respiratory, and other generic and specialty products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Prev. Close
45.1095
Open
45.4372
High
45.4372
Low
45.1095
52 wk Range
44.3574-56.591
Market Cap
4 994 M
P/E Ratio
13.503
Shares Outstanding
111 M
Revenue
3 216 M
EPS
1.07
Dividends (Yield)
0.0186
Beta
0.6
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Hikma Pharmaceuticals PLC ADR data using free add-ons & libraries
Get Hikma Pharmaceuticals PLC ADR Fundamental Data
Hikma Pharmaceuticals PLC ADR Fundamental data includes:
- Net Revenue: 3 216 M
- EBITDA: 764 M
- Earnings Per Share: 3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-07
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Hikma Pharmaceuticals PLC ADR News
New
If EPS Growth Is Important To You, Hikma Pharmaceuticals (LON:HIK) Presents An Opportunity
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage ...
We bought this stock cheap and it’s getting cheaper
Questor is The Telegraph’s stock-picking column, helping you decode the markets and offering insights on where to invest. As the American investment writer Jim Grant said: “Successful investing i...
One Hikma Pharmaceuticals Insider Raised Stake By 14% In Previous Year
Explore Hikma Pharmaceuticals's Fair Values from the Community and select yours From what we can see, insiders were net buyers in Hikma Pharmaceuticals PLC's (LON:HIK ) during the past 12 months. Tha...
Hikma shares drop 7% on weaker margins despite solid revenue, maintained outlook
Investing.com -- Hikma Pharmaceuticals (OTC:HKMPY) shares fell more than 7% on Thursday after the company reported lower first-half margins in its injectables and U.S. generics units, even as it poste...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
